Arovella Therapeutics has an EPS of $-0.0143. In 2022, the company made an earnings per share (EPS) of $-0.0157. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.0143 | -8.92% |
2022 | -$0.0157 | 3.29% |
2021 | -$0.0152 | -74.30% |
2020 | -$0.059136 | - |